TITLE
ChIPseq analysis of patient-derived luminal breast cancer xenografts with progestins

ORGANISM
Homo sapiens

SUMMARY
Primary breast cancer xenografts

DESIGN
Primary xenograft treated with estrogen or estrogen plus progesterone in triplicate. ChIP for estrogen receptor, progesterone receptor. Includes input and IgG negative control.

PLATFORM
GPL16791 Illumina HiSeq 2500 (Homo sapiens)

CITATIONS
Has this study been published? Please login to update or notify GEO .

